Ishigaki K, et al. J. Clin. Endocrinol. Metab. (2002) cited as Ref 133 in DOI: 10.1038/s41392-020-0110-5 (Q9396)

From Wikibase.slis.ua.edu
Revision as of 15:31, 21 May 2020 by Admin (talk | contribs) (‎Created claim: Property:P105: 3433-3440, #quickstatements; #temporary_batch_1590074839150)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Ishigaki K, et al. J. Clin. Endocrinol. Metab. (2002) cited as Ref 133 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    First Author string
    Ishigaki K
    0 references
    PubMed ID
    12107263
    0 references
    Publication Date
    2002
    0 references
    Published In Name String
    J. Clin. Endocrinol. Metab.
    0 references
    Volume
    87
    0 references
    title
    Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancer (English)
    0 references
    Page(s)
    3433-3440
    0 references
     

    Sitelinks

    Retrieved from "http://wikibase.slis.ua.edu/w/index.php?title=Item:Q9396&oldid=205321"